Literature DB >> 19809543

Turnover modeling of non-esterified fatty acids in rats after multiple intravenous infusions of nicotinic acid.

Christine Isaksson1, Johan Gabrielsson, Kristina Wallenius, Lambertus A Peletier, Helena Toreson.   

Abstract

The objective of this investigation was to use a pharmacokinetic (PK)/pharmacodynamic (PD) approach to describe and evaluate a PK model of nicotinic acid (NiAc) in guinea pigs and a PD feedback model of changes in non-esterified fatty acid (NEFA) concentrations in rats following multiple intravenous infusions of NiAc at different rates and durations of inhouse and literature (NEFA after extravascular NiAc dosing) data. Serial arterial blood samples were taken for evaluation of NiAc exposure in guinea pigs and NEFA in rats. The biophase kinetics of NiAc was assumed to impact on NEFA turnover with feedback incorporated via an inhibitory moderator compartment. The response acted linearly on the production of moderator, which then acted inversely on the turnover rate of response. The potency, expressed as the amount of NiAc in the biophase causing a 50 % inhibitory effect (ID(50)), was 6.5 nmol +/- 31 % and the half-life of response (t(1/2, kout)) 2 min +/- 18 %. The half-life of tolerance (t(1/2, ktol)) was 9 min +/- 27 %. The model can be used to provide information about factors that determine the time course of NEFA response following different rates and routes of administration of NiAc or NiAc analogues.

Entities:  

Year:  2009        PMID: 19809543      PMCID: PMC2754538          DOI: 10.2203/dose-response.08-028.Isaksson

Source DB:  PubMed          Journal:  Dose Response        ISSN: 1559-3258            Impact factor:   2.658


  23 in total

1.  Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena.

Authors:  A Sharma; W F Ebling; W J Jusko
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

2.  Studies on the effect of nicotinic acid on catecholamine stimulated lipolysis in adipose tissue in vitro.

Authors:  L A CARLSON
Journal:  Acta Med Scand       Date:  1963-06

3.  Dynamics of a metabolic system: what single-action agents reveal about acid secretion.

Authors:  V Licko; E B Ekblad
Journal:  Am J Physiol       Date:  1992-03

4.  GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.

Authors:  Zoltán Benyó; Andreas Gille; Jukka Kero; Marion Csiky; Marie Catherine Suchánková; Rolf M Nüsing; Alexandra Moers; Klaus Pfeffer; Stefan Offermanns
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 5.  A flexible nonlinear feedback system that captures diverse patterns of adaptation and rebound.

Authors:  Johan Gabrielsson; Lambertus A Peletier
Journal:  AAPS J       Date:  2008-02-22       Impact factor: 4.009

6.  Quantitative determination of drug bioavailability and biokinetic behavior from pharmacological data for ophthalmic and oral administrations of a mydriatic drug.

Authors:  V F Smolen
Journal:  J Pharm Sci       Date:  1971-03       Impact factor: 3.534

7.  Insulin response and changes in composition of non-esterified fatty acids in blood plasma of middle-aged men following isoenergetic fatty and carbohydrate breakfasts.

Authors:  D L Frape; N R Williams; K L Carpenter; M A Freeman; C R Palmer; R J Fletcher
Journal:  Br J Nutr       Date:  2000-11       Impact factor: 3.718

8.  Molecular identification of nicotinic acid receptor.

Authors:  Takatoshi Soga; Masazumi Kamohara; Jun Takasaki; Shun-ichiro Matsumoto; Tetsu Saito; Takahide Ohishi; Hideki Hiyama; Ayako Matsuo; Hitoshi Matsushime; Kiyoshi Furuichi
Journal:  Biochem Biophys Res Commun       Date:  2003-03-28       Impact factor: 3.575

9.  PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect.

Authors:  Sorin Tunaru; Jukka Kero; Annette Schaub; Christian Wufka; Andree Blaukat; Klaus Pfeffer; Stefan Offermanns
Journal:  Nat Med       Date:  2003-02-03       Impact factor: 53.440

10.  Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists.

Authors:  Ester Carballo-Jane; Lynn S Gerckens; Silvi Luell; Allison S Parlapiano; Michael Wolff; Steven L Colletti; James R Tata; Andrew K P Taggart; M Gerard Waters; Jeremy G Richman; Margaret E McCann; Michael J Forrest
Journal:  J Pharmacol Toxicol Methods       Date:  2007-06-23       Impact factor: 1.950

View more
  8 in total

Review 1.  Pattern Recognition in Pharmacodynamic Data Analysis.

Authors:  Johan Gabrielsson; Stephan Hjorth
Journal:  AAPS J       Date:  2015-11-05       Impact factor: 4.009

2.  Feedback modeling of non-esterified fatty acids in rats after nicotinic acid infusions.

Authors:  Christine Ahlström; Lambertus A Peletier; Rasmus Jansson-Löfmark; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-04       Impact factor: 2.745

3.  Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions.

Authors:  Christine Ahlström; Tobias Kroon; Lambertus A Peletier; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-10-10       Impact factor: 2.745

4.  Challenges of a mechanistic feedback model describing nicotinic acid-induced changes in non-esterified fatty acids in rats.

Authors:  Christine Ahlström; Lambertus A Peletier; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-07-04       Impact factor: 2.745

5.  Dynamic modeling of methylprednisolone effects on body weight and glucose regulation in rats.

Authors:  Jing Fang; Debra C DuBois; Yang He; Richard R Almon; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-03-11       Impact factor: 2.745

6.  Joint feedback analysis modeling of nonesterified fatty acids in obese Zucker rats and normal Sprague-Dawley rats after different routes of administration of nicotinic acid.

Authors:  Sofia Tapani; Joachim Almquist; Jacob Leander; Christine Ahlström; Lambertus A Peletier; Mats Jirstrand; Johan Gabrielsson
Journal:  J Pharm Sci       Date:  2014-07-01       Impact factor: 3.534

7.  Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatments.

Authors:  Robert Andersson; Tobias Kroon; Joachim Almquist; Mats Jirstrand; Nicholas D Oakes; Neil D Evans; Michael J Chappel; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-21       Impact factor: 2.745

8.  Frequency-Domain Response Analysis for Quantitative Systems Pharmacology Models.

Authors:  Pascal Schulthess; Teun M Post; James Yates; Piet H van der Graaf
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-11-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.